Recruiting NA INTERVENTIONAL 2-arm
NCT07433504
A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.
A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Transcatheter Tricuspid Valve Clipping Systems in Patients With Severe or Greater Tricuspid Regurgitation.
Sponsor: Shanghai Huihe Medical Technology Co., Ltd
Conditions
Severe or Greater Tricuspid Regurgitation
Interventions
Experimental: Transcatheter tricuspid valve repair using the transcatheter tricuspid valve clipping system +GDMT Guideline Directed Medical Therapy
Updated 1 time since 2026 Last updated: Feb 20, 2026 Started: Jan 28, 2026 Primary completion: Dec 31, 2027 Completion: Dec 31, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07433504, this NA trial focuses on Severe or Greater Tricuspid Regurgitation and remains actively recruiting participants. Sponsored by Shanghai Huihe Medical Technology Co., Ltd, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Shanghai Huihe Medical Technology Co., Ltd
Data source: Shanghai Huihe Medical Technology Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .